RNAC
NASDAQ · Biotechnology
Cartesian Therapeutics Inc
$8.54
+0.12 (+1.43%)
Open$8.51
Previous Close$8.42
Day High$8.57
Day Low$8.12
52W High$15.57
52W Low$5.60
Volume—
Avg Volume195.3K
Market Cap218.30M
P/E Ratio—
EPS$-5.80
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+376.1% upside
Current
$8.54
$8.54
Target
$40.66
$40.66
$22.44
$40.66 avg
$45.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.75M | 9.38M | 132.93M |
| Net Income | -128,242,484 | -393,381,852 | 3.48M |
| Profit Margin | -4,658.6% | -4,425.7% | 2.6% |
| EBITDA | -140,852,518 | -456,066,435 | 5.52M |
| Free Cash Flow | — | — | 2.68M |
| Rev Growth | -70.7% | -70.7% | -1.8% |
| Debt/Equity | 0.28 | 0.28 | 0.86 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |